J. S. Kim

发表

Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis

S. Kopetz, A. Parikh, M. Jen, 2022, The oncologist.

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Jae Hyun Kim, Yoon-Koo Kang, Jin-Hyuk Choi, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer.

J. Vansteenkiste, F. Barlesi, B. Besse, 2019, Lung cancer.

Safety outcomes in advanced non-small-cell lung cancer patients treated with first-line platinum-based regimens in the United States.

W. John, Lei Chen, B. San Antonio, 2019, Journal of thoracic disease.

Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies.

M. Rizzo, E. Garon, P. Peterson, 2021, Clinical lung cancer.

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea

H. Birnbaum, Y. Bang, R. Cheng, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Joon-Oh Park, Chiun Hsu, Li‐Tzong Chen, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189

S. Gadgeel, M. Rizzo, J. Gray, 2022, JTO clinical and research reports.

Pemetrexed maintenance with or without pembrolizumab in non-squamous non-small cell lung cancer: A cross-trial comparison of KEYNOTE-189 versus PARAMOUNT, PRONOUNCE, and JVBL.

R. Govindan, E. Garon, J. S. Kim, 2020, Lung cancer.

A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer.

M. Socinski, K. Syrigos, D. Mavroudis, 2019, Lung cancer.

Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study

K. Papadopoulos, J. Bendell, A. Naing, 2021, International journal of cancer.

Real-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USA.

H. Aggarwal, Yimei Han, Y. Zhu, 2023, Immunotherapy.

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial.

Chun-Ming Tsai, J. Yang, Jin-Hyoung Kang, 2016, Clinical lung cancer.

Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

M. Ahn, Keunchil Park, E. Cho, 2015, Cancer research and treatment : official journal of Korean Cancer Association.